Ophthalmology Doctors in West Allis, WI Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

Dr. Mark Freedman, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10150 W National Ave, West Allis, WI 53227 Phone: 414-321-7520    Fax: 414-321-9383

Daniel Ferguson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10150 W National Ave, West Allis, WI 53227 Phone: 414-321-7520    Fax: 414-321-9383

Brett Rhode, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10150 W National Ave, Suite 100, West Allis, WI 53227 Phone: 414-321-7520    Fax: 414-321-9383

Richard D Davenport, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2424 S 90th St, Ste 506, West Allis, WI 53227 Phone: 414-328-8760    Fax: 414-328-8763

Robert Sucher, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 10150 W National Ave, West Allis, WI 53227 Phone: 414-321-7520    Fax: 414-321-9383

Daniel M Paskowitz, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 10150 W National Ave, West Allis, WI 53227 Phone: 414-321-7520

News Archive

Study explores connection between ideology, social capital and health

The nation's left-leaning citizens might be pleased by the findings of a new University of Nebraska study that finds those who live in liberal states tend to be healthier.

Among those disrupted by COVID-19: The nation's newest doctors

July 1 is a big day in medical education. It's traditionally the day newly minted doctors start their first year of residency. But this year is different. Getting from here to there — from medical school to residency training sites — has been complicated by the coronavirus.

Amphion Innovations reports interim results for the six months ended 30 June 2009

Amphion Innovations plc (LSE: AMP) ("Amphion" or the "Company"), the developer of medical and technology businesses, today announces its unaudited interim results for the six months to 30 June 2009.

U.S. District Court rules in favor of Teva in COPAXONE patent infringement case

Teva Pharmaceutical Industries Ltd. announced today the U.S. District Court for the Southern District of New York has found in favor of Teva in the Company's patent infringement lawsuit against Momenta Pharmaceuticals, Inc./Sandoz Inc. and Mylan Laboratories Inc./Natco Pharmaceuticals regarding Teva's relapsing-remitting multiple sclerosis (RRMS) product, COPAXONE.

Read more Medical News

› Verified 1 days ago